| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |